Biotechnology State Economic Development Post-COVID: Where Public-Private Partnerships Succeed

3:00 PM - 3:45 PM (EDT), Thursday, June 17, 2021
Search General Info
Search Education
Search Partnering Companies

Advances in biotechnology innovation have had a vital impact on the U.S. economy — life-saving drugs and vaccines during the era of COVID, protecting plants that are key to feeding the world and industrial biotechnology applications that are leading to bio-based fuels, chemicals and products that can protect our environment.
The bioscience’s need for a stable and supportive public policy framework is vital to industry companies large and small and state lawmakers have become increasingly aware of these unique opportunities.
One such state is Texas with its recent public referendum—the $3 Billion Cancer Prevention and Research Institute of Texas—a multi-year, state-supported strategy voted in by their citizens to generate vital public-private partnerships in health care research focused on cancer and related diseases.

Speakers from state government, academic researchers, and the industry will share their insights on this successful effort that can be utilized by other states in their economic development efforts.

Moderator
photo
Senior Policy Adviser- Federal and State Economic Development
PMP Public Affairs Consulting
Speakers
photo
Executive Director
Office of the Governor, Texas Economic Development & Tourism
photo
Principal & Project Director
TEConomy Partners
photo
President & CEO
Texas Healthcare & Bioscience Institute
photo
Senior Policy Adviser- Federal and State Economic Development
PMP Public Affairs Consulting
photo
Chief Product Development Officer
Cancer Prevention and Research Institute (CPRIT)